The re-rate journey, page-474

I note that order is now gone also

I asked IR the below for tomorrows webinar:

- Is it a coincidence around the recent creation of the FFN test site in AUS and the development of the FFN test with LDX?
- With Febridx available in Aus / NZ through the HS channel, are there any specific GP offices that are available through currently or is it a matter of these offices ordering the product through RHCG on request? Have any GP groups in Australia engaged to take on the product at this stage?

Also, not sure if anyone looked but Hologic released its report yesterday. I am curious where the expense for LDX would be categorised on their report for the $5M paid out this last quarter. Would it be under R&D?

If so, the total outlay for the quarter was 64.1Million USD.

$5Million of that to LDX plus any other services revenue LDX made in the quarter from other services they continue to provide? Nearly 8% of their R&D for this quarter went to LDX?